Wordt geladen...
First‐Pass CYP3A‐Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates
To predict first‐pass and systemic cytochrome P450 (CYP) 3A‐mediated metabolism of midazolam in preterm neonates, a physiological population pharmacokinetic model was developed describing intestinal and hepatic midazolam clearance in preterm infants. On the basis of midazolam and 1‐OH‐midazolam conc...
Bewaard in:
| Gepubliceerd in: | CPT Pharmacometrics Syst Pharmacol |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6027733/ https://ncbi.nlm.nih.gov/pubmed/29745466 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/psp4.12295 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|